BOS 0.00% 1.5¢ biosignal limited

deal, page-6

  1. 1,189 Posts.
    lightbulb Created with Sketch. 1
    Just adding to the previous informative posts. This is my take on the announcement and assumes a conversion rate of US$0.80 to AUD$1.00.

    BOS to be issued 2.6 million CBTE shares x AUD$ 0.975 (US$0.78 now) = $ 2.535 million

    Assuming 111 million shares on issue + 12 million to be issued = 123 million shares

    $ 2.535 million divided by 123 million = $ 0.02 cps

    If full conversion of convertible note is issued.
    114 million shares x AUD$0.03 = $3.42 million

    $3.42 million + $2.535 million = $5.955 million

    $5.955 million divided by 237 million shares (123 mill + 114 mill ) = $0.025 cps

    Assuming that all 114 million shares are issued then every US$0.10 cent rise in the CBTE share price would mean a $0.0014 rise in the BOS share price.
    (2.6 million CBTE x AUD$0.125 = $325,000 divided by 237 million shares)

    We need more information of course and some of this funding will no doubt be spent on the “major acquisition”. Also this valuation is placed solely on the deal at hand and doesn’t include any other assets or liabilities in the company at present.

    Hope the figures are correct. At least it keeps BOS alive and exposed to further potential.
 
watchlist Created with Sketch. Add BOS (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.